Riskpilot← Back to searchSign inGet full accessCONCIT PHARMA HOLDING ApS
APSIn liquidationCVR 33061374Langåsen 3Activities of holding companies · NACE 6421Est. 2010— employees
Revenue 2023
DKK -31K
+14% vs 2022
EBITDA margin
100.0%
+97% vs 2022
Equity ratio
89.5%
Financial strength
Net profit 2023
DKK -32K
+83% vs 2022
| Revenue | DKK -31K | +14% |
| EBITDA | DKK -31K | +97% |
| Net profit | DKK -32K | +83% |
| Total assets | DKK 733K | -61% |
| Equity | DKK 656K | -5% |
| Employees | — | — |
Legal name
CONCIT PHARMA HOLDING ApS
CVR number
33061374
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
9. juli 2010
Share capital
DKK 306.300
Employees
—
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Address
Langåsen 3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -11 | -10 | -14 | -22 | -319 | -10 | -84 | -173 | -38 | -28 | -27 | -31 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -11 | -10 | -14 | -22 | -319 | -10 | -84 | -173 | -38 | -28 | -1.209 | -31 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -11 | -10 | -14 | -22 | -319 | -10 | -84 | -173 | -38 | -28 | -1.209 | -31 |
| Net financials | -3 | -3 | -239 | 155 | 7.211 | -3 | 17 | -306 | 20 | -1.059 | 1.022 | -1 |
| Profit before tax | -14 | -13 | -253 | 133 | 6.892 | -13 | -66 | -479 | -18 | -1.086 | -187 | -32 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -14 | -13 | -253 | 133 | 6.892 | -13 | -66 | -479 | -18 | -1.086 | -187 | -32 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 478 | 386 | 161 | 415 | 7.094 | 6.584 | 6.595 | 6.065 | 3.029 | 1.971 | 1.856 | 733 |
| Equity | 278 | 265 | 13 | 146 | 7.038 | 6.525 | 6.458 | 5.979 | 2.961 | 875 | 688 | 656 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 199 | 121 | 149 | 269 | 56 | 59 | 136 | 86 | 68 | 1.097 | 1.169 | 77 |
| Total debt | 199 | 121 | 149 | 269 | 56 | 59 | 136 | 86 | 68 | 1.097 | 1.169 | 77 |
EBITDA margin
-3124700.0%
This company
15.8%
Market median
-19776682% vs market
20122023
Equity ratio
89.5%
This company
38.2%
Market median
+134% vs market
20122023
Return on equity
-4.8%
This company
18.4%
Market median
-126% vs market
20122023
Net profit margin
-3176800.0%
This company
8.1%
Market median
-39219853% vs market
20122023
Asset turnover
-0.04×
This company
1.12×
Market median
-104% vs market
20122023
Debt / equity
0.12×
This company
0.62×
Market median
+81% vs market
20122023
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
JBHA Holding ApS | Company | 50.0% | 50.0% | 2019 |
| Individual | 50.0% | 50.0% | 2010 | |
Thomsen Pharma ApS | Company | 50.0% | 50.0% | 2019 |
| Individual | 50.0% | 50.0% | 2010 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CONCIT PHARMA HOLDING ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|